The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2021 | Multimarker approach to CTC analysis in CTCL
Maarten Vermeer
• 15 Oct 2021
Maarten Vermeer, MD, PhD, Leiden University Medical Center, Leiden, Netherlands, gives an overview of the multimarker approach to biomarker research and its role in the quantification of circulating tumor cells (CTCs) for diagnosis and treatment-response analysis in cutaneous T-cell lymphoma (CTCL). This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
